Effects of nursing intervention based on Information-motivation-behavior model on self-efficacy and quality of life of patients with primary liver cancer
10.3760/cma.j.issn.1674-2907.2018.14.017
- VernacularTitle:基于信息-动机-行为模型的护理干预对原发性肝癌患者自我效能及生活质量的影响
- Author:
Hualan ZHU
1
;
Xiaolan WANG
Author Information
1. 暨南大学附属第一医院肝胆外科
- Keywords:
Liver neoplasms;
Quality of life;
Self-efficacy;
Information-motivation-behavioral model
- From:
Chinese Journal of Modern Nursing
2018;24(14):1677-1681
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the effects of nursing intervention based on Information-motivation-behavioral model (IMB) on self-efficacy and quality of life of patients with primary liver cancer. Methods A total of 84 patients with primary liver cancer who were hospitalized in the First Affiliated Hospital of Ji'nan University from January to December in 2016 were selected by convenience sampling method and divided into control group (40 cases) and observation group (44 cases) according to the time of admission. The patients in the control group received routine care, while the patients in the observation group received nursing intervention based on IMB. Chinese Strategies Used by People to Promote Health (C-SUPPH) and Quality of Life-Liver Cancer (QOL-LC) were applied to investigate patients' self-efficacy and quality of life before and after intervention, so as to evaluate the effects of intervention. Results The C-SUPPH and QOL-LC scores of the observation group and the control group were (87.18±14.83), (105.01±18.56) and (78.65±15.75),(94.75±18.15) respectively on the day of discharge, and the differencs were statistically significant (t=-2.557,-2.068; P< 0.05). The C-SUPPH and QOL-LC scores of the observation group and the control group were (92.34±16.04), (123.11±20.86) and (80.50±15.86), (101.90±19.95) respectively 1 month after discharge, and the differences were statistically significant (t=-3.397,-4.753; P< 0.05). Conclusions Nursing intervention based on IMB can improve the self-efficacy and quality of life of patients with primary liver cancer, which is worthy of clinical promotion.
